ARAlireza Rajaei

Alireza Rajaei

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alireza Rajaei has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Post Varicella-Zoster virus transverse myelitis: Diagnostic and therapeutic challenges – A case report and literature review

    by Mohammad Mehdi Shadravan, Farnoosh Farshchian, Alireza Rajaei, Ilad Alavi Darazam, Reza Naseri, Faezeh Maghsudloo


  • Open Access

    Compared Efficacy of Tocilizumab versus Rituximab in the Treatment of Refractory Rheumatoid Arthritis: A Randomized Clinical Trial study

    by Arman Ahmadzadeh, Faraneh Farsad, Alireza Rahaei, Mohammad Mehdi Emam, Latif Gachkar, Elnaz Shafighi Shahri

    Background & Objective: This study was carried out to compare the efficacy of tocilizumab versus rituximab in the treatment of refractory rheumatoid arthritis. Materials & Methods: Twenty-two women with refractory rheumatoid arthritis were randomly divided into rituximab (n= 11) and tocilizumab (n= 11) treatment groups. In the first group, rituximab ...


  • Open Access

    Investigation of the level of agreement between bone mineral density and trabecular bone score regarding gender, age and body mass index

    by Alireza Rajaei, Ideh Kamkar, Faraneh Farsad

    Introduction: Increasing and maintaining bone density can play a role in preventing osteoporosis, as changes in the trabecular bone score (TBS) and bone mineral density (BMD) affect bone density, especially in the spine. Objectives: The present study aimed to determine the level of agreement between TBS and BMD in patients with osteoporosis and also to investigate the relationship between these two indices with body mass index (BMI). Patients and Methods: Data were collected from 843 patients, referred to the densitometry department of Resalat hospital. BMD and TBS were measured in the subjects to determine the risk of osteoporosis. The results of BMD were measured based on T-score level. The patients’ individual and clinical characteristics were also recorded and factors influencing the prognosis of density changes were evaluated. Moreover, the effect of BMI was investigated in this study. Results: The mean age of patients was 55.5 years. The kappa coefficient and Spearman’s correlation coefficient of BMD and TBS were 0.004 and -0.015, respectively. There was a significant correlation between BMI and BMD in men. The kappa coefficient gradually increased from normal bone density to osteoporosis. There was a significant negative correlation between BMI and BMD, while a significant positive correlation between height and BMD in women was existed. On the other hand, a significant negative correlation between weight and BMD was detected accordingly. Conclusion: According to the results of our study, there is no agreement between BMD and TBS.


  • Open Access

    Serial or compare bone mineral densitometry: how to do it step by step

    by Alireza Rajaei

    Bone mineral densitometry (BMD) is the most valuable method for assessing bone and calculating fracture risk. Serial or comparative bone densitometry is important in rheumatologists' work on osteoporosis management. The response or lack of response to osteoporosis treatment based on densitometry scans is crucial. This paper examines the timing of scan requests concerning the history of glucocorticoid use, renal or other solid organ transplantation, malignancy, and other situations discussed. We encountered four types of compared scans based on the centers where BMD was performed and the precision of the devices used for this survey: Same Center, Same Device (SSSD), Same Center Different Devices (SCDD), Different Centers Same Devices (DCSD), and Different Centers Different Devices (DCDD). We discussed the principles of comparison and the key indicators.


  • Open Access

    Diagnostic Value of Trabecular Bone Score in Osteoporosis

    by Alireza Rajaei, Khatereh Mohammadi, Mahbobeh Oroei, Faraneh Farsad

    Background: Osteoporosis is a common chronic disease that can cause fractures and other complications. Early diagnosis and prompt treatment of this disease can reduce the risk of fracture. The trabecular bone score (TBS) is a valuable tool for evaluating bone microarchitecture in patients with osteoporosis. Objectives: The present study aimed to evaluate the association of TBS score with bone mineral density (BMD) as the gold standard in patients with osteoporosis. Patients and Methods: This cross-sectional study was performed on 254 patients admitted to Resalat Hospital in Tehran, Iran. The BMD and TBS were concurrently evaluated, and TBS validity for osteoporosis diagnosis was assessed based on BMD as the gold standard. The agreement between TBS and BMD results was measured using the kappa statistic. All analyses were performed in MedCalc version 18.11.3.8 and SPSS version 18, and the level of statistical significance was set at < 0.05. Results: In this study, the majority of the patients were female (88.2%) and younger than 65 years (63.0%). Osteopenia and osteoporosis were diagnosed in 42.1% and 18.9% of the patients, respectively. The sensitivity of TBS for diagnosing osteoporosis versus osteopenia and osteopenia versus a normal status was higher in patients aged ≥ 65 years compared to those aged < 65 years (63.33% vs. 27.78% and 86.66% vs. 63.63%, respectively). Overall, TBS demonstrated a high diagnostic ability for differentiating osteoporosis versus normal BMD (AUC = 0.911, P < 0.001). Conclusion: Based on the findings, TBS alone is not sufficient for diagnosing osteoporosis and cannot replace BMD. Therefore, a combination of BMD and TBS techniques can be the best approach for diagnosing osteoporosis, especially in patients aged ≥ 65 years.

  • Open Access

    A comparison between the total and best regions of trabecular bone scores and evaluating the added value of combining the trabecular bone scores with bone-mineral density

    by Alireza Rajaei, Pooneh Dehghan, Samaneh Hatami

    Introduction: Bone mineral density (BMD) and trabecular bone score (TBS) are recognized as two indexes for diagnosis of osteoporosis. Objectives: The present study assesses the TBS performance as an alternative test for BMD. Patients and Methods: A retrospective descriptive study conducted on 2,106 patients were referred to two central hospitals; Resalat and Loghman in Tehran, Iran. Necessary data have been collected for the analysis process, including age, gender, body mass index, and L1-L4 TBS. Results: Four-hundred eligible patients were considered for our analysis process. Among these patients, about 13.8 and 86.3% were men and women with mean ages of 54.04 ± 10.92 and 53.83 ± 10.16 years, respectively (P=0.88). Our study showed a statistically significant difference between the mean TBS of all regions in patients (P=0.001), while this value was dependent on the gender and age of patients. The mean TBS of all regions in women younger than 50 years was significantly higher than those older than 50 years (P<0.001). Moreover, a statistically significant difference was observed between the means of the best regional TBS in all study groups (P<0.001). This study showed the lumbar spine TBS had a negative correlation with body mass index in women, while this correlation was not significant in men. Conclusion: Trabecular bone score can be conducted as a complementary index along with BMD, it can be employed independently as an appropriate indicator for osteoporosis.


  • Open Access

    Correlation between capillaroscopic findings and bone mineral density results in the systemic lupus erythematosus patients

    by Alireza Rajaei, Haleh Sadraee, Pooneh Dehghan, Mohammad Mehdi Emam, Arman Ahmadzadeh, Faraneh Farsad, Zahra Abbasi

    Introduction: Systemic lupus erythematosus (SLE) is an autoimmune disorder that can cause vascular involvement. The vascular changes can be seen in the bed of the nails. It was observed that SLE has a relationship with bone mineral density (BMD) changes. Objectives: This study aimed to investigate the frequency and types of capillaroscopic change in SLE and its relationship between capillaroscopic changes with BMD in SLE. Patients and Methods: Thirty-three patients with SLE who were referred to Resalat hospital (Tehran, Iran) underwent nailfold capillaroscopy (NFC). In addition, these patients were evaluated for BMD from spine and hip. Moreover, the correlation of these data was assessed. Result: Scleroderma pattern was seen in 12.12% of patients, non-scleroderma pattern (NSP) in 27.3% patients and normal pattern in 60.6% based on NFC. There was no relationship between gender and NFC. The mean age was 43.30 years and 78.8% of patients were female. Dimension and morphological abnormalities had a relationship with scleroderma pattern (P=0.033 and P=0.014 respectively). There was a relationship between spine BMD and morphological abnormality too (P=0.013). Conclusion: NFC is a good method for evaluating vascular change in patients with SLE and in this method, abnormal morphology and dimension have higher prevalence than other abnormalities in patients with SLE. Additionally, a relationship between abnormal morphology in NFC and spinal osteoporosis in SLE patients was detected.

  • Open Access

    The prevalence of COVID-19 in patients with rheumatoid arthritis, multiple sclerosis, or systemic lupus erythematosus receiving biologic disease-modifying antirheumatic drugs

    by Arman Ahmadzadeh, Faraneh Farsad, Mohammad Mehdi Emam, Alireza Rajaei, Samaneh Hatami, Latif Gachkar

    Introduction: The coronavirus disease (COVID-19) became a global pandemic in 2019. Some studies have shown that the virus can cause a higher mortality in people with weakened immune systems, such as the elderly, those taking immunosuppressive drugs, and those with underlying disorders, than in the general population. Objectives: The aim of this study was to evaluate the prevalence of COVID-19 in patients with rheumatic disorders who received biologic disease-modifying antirheumatic drugs (DMARDs). The effect of precautionary self-isolation in these patients was also determined. Patients and Methods: This descriptive study involved 200 patients with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and multiple sclerosis (MS) who were treated with biologic DMARDs. Patients with symptoms of the coronavirus infection were invited to have a COVID-19 test that involved a COVID-19 IgG antibody test or a polymerase chain reaction (PCR) test (i.e., nasal swab). Additionally, patients were asked about their precautionary self-isolation status during this period. Results: The mean age of the patients was 51.29 years ± 13.38 years. The ratio of males to females was 27 to 173. Of the 200 patients included in the study, 156 (78%) had RA, 10 (5%) had SLE, and 34 (17%) had MS. Seventy-five percent of the patients used rituximab. Ten patients (5%) were symptomatic of COVID-19, although only four patients had a definitive diagnosis of the disease. All patients who were symptomatic of COVID-19 took rituximab. Ten percent of patients who did not observe the precautionary self-isolation period were diagnosed with COVID-19. Conclusion: Patients who receive biologic DMARDs have a lower risk of developing COVID-19 and a lower risk of mortality from the disease than the general population.

  • Open Access

    Application of Data Envelopment Analysis (DEA) in choosing the proper Magnetic Resonance Imaging (MRI) machine

    by Pooneh Dehghan, Alireza Rajaei, Reza Zandi, Shahin Mehdipour, Salar Taki, Homayoun Hadizadeh Kharazi, Seyyed Hasan Langari

    This study is aimed to apply one of the decision-making tools, Data Envelopment Analysis (DEA) in the field of imaging in health care for choosing the most efficient model of Siemens MRI machines for clinical purposes. A list of Siemens MRI machines with their corresponding details such as price and technical characteristics were collected as mentioned in the machine booklets and through consultation with Siemens representative in the country. Variables were defined and categorized as input and output and the linear mathematical model for each machine was written and calculated using the super-efficiency model to find the most efficient Siemens MRI machine and rank the available models using DEA. The results showed that the most efficient model of Siemens MRI is Prisma (Super-efficiency score = 2.009302) followed by Skyra (Super-efficiency score = 1.697531) and Sola (Super-efficiency score = 1.683571). Data Envelopment Analysis (DEA) is recommended as the decision-making tool for selecting advanced technologies in healthcare since it can handle substantial number of variables as input and output and unlike other decision-making tools such as Analytic Hierarchy Process (AHP) which is widely used in this industry, the weight of each variable is determined by the linear mathematical model which makes it reproduceable and reliable.